AdaptHealth Corp.
AHCO Healthcare Medical Devices
In the quarter to June 2026, revenue grew 12.7%, EPS fell 1,090.0%, free cash flow fell 128.6% and total debt rose 4.30%, each against the same quarter a year earlier. Operating cash flow growth for five consecutive years; insiders bought in the last twelve months.
Follow AHCO
AdaptHealth Corp. (AHCO) EV/Sales
As of 16 October 2026, AdaptHealth Corp. (AHCO) trades at a EV/Sales of 0.8×. Over the past ten years it has ranged from 0.0× (December 2019) to 4.4× (April 2021); the current reading is higher than 21% of that period. That is below the Medical Devices industry median of 2.2× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 0.9× | (4.59%) |
| FY2024 | 1.0× | 1.39% |
| FY2023 | 1.0× | (39.93%) |
| FY2022 | 1.6× | (23.51%) |
| FY2021 | 2.1× | (15.90%) |
| FY2020 | 2.5× | 129.01% |
| FY2019 | 1.1× | — |
| FY2018 | 0.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 1.0× | (6.25%) |
| Mar 2026 | 1.0× | 12.25% |
| Dec 2025 | 0.9× | (0.96%) |
| Sep 2025 | 0.9× | (4.57%) |
| 26 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| AHCO AdaptHealth Corp. | 0.8× |
| INMD InMode Ltd. compare | 0.9× |
| LMRI Lumexa Imaging Holdings, Inc. compare | 1.0× |
| VREX VAREX IMAGING compare | 1.2× |
| QDEL QuidelOrtho Corporation compare | 1.4× |
| IART Integra LifeSciences Holdings Corporation compare | 1.6× |
| PRCT PROCEPT BioRobotics Corporation compare | 2.5× |
| SIBN SiBone compare | 3.6× |
| BBNX Beta Bionics, Inc. compare | 4.6× |
| Medical Devices industry median | 2.2× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)